SEEKING TO REVOLUTIONIZE CLINICAL TRIALS STARSPHERE K.K. SECURES SERIES A FINANCING
SEEKING TO REVOLUTIONIZE CLINICAL TRIALS
STARSPHERE K.K. SECURES SERIES A FINANCING
Tokyo, Japan [15 November 2016] – Starsphere is extremely pleased to announce that it has completed its ‘Series A’ financing, successfully securing 130 million Japanese Yen in capital. This round of financing was led by Nissay Life Insurance Capital Corporation (Nissay Capital) which has invested 100 million yen. The remaining 30 million Japanese yen was invested by Kanagawa Science Park (KSP). Starsphere will use this financing to help drive product development, growth and overseas expansion in 2017.
Company President and CEO, Steve van Maanen commented: “This is a remarkable milestone for Starsphere. Having the support of well-established and reputable organizations such as Nissay and KSP is a strong vote of confidence in our firm and our core product DokodemoForm®EDC. This investment will provide a strong foundation for the future of our company.”
Providing a wide range of IT solutions, Starsphere is most notable for developing and providing the cloud-based EDC (electronic data collection) solution “DokodemoForm®EDC”. DokodemoForm®EDC is the first product in Japan with the mission to continually enhance the way data is collected, analyzed and used in life sciences to allow the introduction of needed treatments in a faster, safer and more effective way.
Shaped by the feedback and experience of clinical researchers, DokodemoForm®EDC was carefully developed as a robust solution that can be quickly rolled out to provide a highly intuitive and easy-to-use interface for a range of EDC users. This not only effectively reduces the time and costs associated with EDC projects, but more importantly increases the accessibility of EDC solutions beyond the established pharmaceutical companies and into the realm of academic research and pharmaceutical startups. Starsphere started accepting orders for DokodemoForm®EDC in May 2016 and the response has been overwhelmingly positive.
About Starsphere: Established in 2012, Starsphere K.K. provides a wide range of IT solutions primarily focused on the healthcare industry. The company’s flagship product is DokodemoForm®EDC which underpins Starsphere’s mission to leverage the latest technologies to continually improve the way data is collected, analysed and used, to ultimately bring more effective and safer treatments to patients who need them.
About Nissay Capital Corporation: Founded in April, 1991, in Tokyo Japan, Nissay Capital Co., Ltd is the venture capital arm of Nippon Life Insurance Company specializing in seed, start-up, early stage, expansion, growth capital, middle stage, and later stage investments. It prefers to invests in information technology services; medical, bio, and healthcare; manufacturing.
About Kanagawa Science Park: KSP, Inc. was established in December 1986 as the core entity of the Kanagawa Science Park, a project designed to realize the “Brain Center Framework” policy of Kanagawa Prefecture and the aim of Kawasaki City to become a mecca for science, technology, and research and development in Japan and Asia. Before completion of the Kanagawa Science Park, KSP, Inc., initiated business incubation in October 1987. As a front runner in this business, KSP, Inc. has been involved in the start-up of over 300 businesses.
Over the long term, KSP, Inc. has established a support system for venture business based on know how accumulated through both successful and failed enterprises. From 1997, KSP, Inc. started a venture capital business to enhance its role as an incubator in accordance with trends in the field of venture
business. Investing in the stock of venture companies is not still undertaken by other incubators in Japan today.
代表取締役 バンマーネン スティーブ